✦ LIBER ✦

Considerations for Development of Surrogate Endpoints for Antifracture Efficacy of New Treatments in Osteoporosis: A Perspective

✍ Scribed by Mary L Bouxsein; Pierre D Delmas

Book ID: 111485578
Publisher: American Society for Bone and Mineral Research
Year: 2008
Tongue: English
Weight: 245 KB
Volume: 23
Category: Article
ISSN: 0884-0431
DOI: 10.1359/jbmr.080301

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Properties of A Nonparametric Test for E

Properties of A Nonparametric Test for Early Comparison of Treatments in Clinical Trials in the Presence of Surrogate Endpoints

✍ E. S. Venkatraman; Colin B. Begg 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 605 KB

CT Scan Hematoma Volume: A Surrogate End

CT Scan Hematoma Volume: A Surrogate Endpoint for the Effect of Treatment in Intracerebral Hemorrhage

✍ B.E. Skolnick; S.M. Davis; N.C. Brun; S.E. Mathew; S.A. Mayer 📂 Article 📅 2006 🏛 American Society for Experimental NeuroTherapeutic 🌐 English ⚖ 47 KB

Development and validation of a new mode

Development and validation of a new model of inflammation in the cat and selection of surrogate endpoints for testing anti-inflammatory drugs

✍ J. M. GIRAUDEL; A. DIQUELOU; P. LEES; P. L. TOUTAIN 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

Development and Validation of a Markov M

Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Treatments in Osteoporosis

✍ Mickaël Hiligsmann; Olivier Ethgen; Olivier Bruyère; Florent Richy; Henry-Jean G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB

Time to onset of antifracture efficacy a

Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis

✍ Steven Boonen; Richard Eastell; Guoqin Su; Peter Mesenbrink; Felicia Cosman; Jan 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 256 KB

Development of a modeling framework to s

Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancer

✍ Laurent Claret; Jian-Feng Lu; Yu-Nien Sun; René Bruno 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 474 KB